WO2010122326A1 - Polymeric materials comprising barium sulphate - Google Patents

Polymeric materials comprising barium sulphate Download PDF

Info

Publication number
WO2010122326A1
WO2010122326A1 PCT/GB2010/050631 GB2010050631W WO2010122326A1 WO 2010122326 A1 WO2010122326 A1 WO 2010122326A1 GB 2010050631 W GB2010050631 W GB 2010050631W WO 2010122326 A1 WO2010122326 A1 WO 2010122326A1
Authority
WO
WIPO (PCT)
Prior art keywords
polymeric material
barium sulphate
impact strength
composition
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2010/050631
Other languages
English (en)
French (fr)
Inventor
Craig Valentine
Andrew Elleray
Keith Cartwright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invibio Ltd
Original Assignee
Invibio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invibio Ltd filed Critical Invibio Ltd
Priority to EP10716014.5A priority Critical patent/EP2421914B1/en
Priority to BRPI1014972A priority patent/BRPI1014972A2/pt
Priority to JP2012506573A priority patent/JP5732044B2/ja
Priority to US13/265,601 priority patent/US20120101185A1/en
Priority to AU2010240703A priority patent/AU2010240703A1/en
Priority to CN201080017478.5A priority patent/CN102405254B/zh
Priority to CA2758605A priority patent/CA2758605A1/en
Publication of WO2010122326A1 publication Critical patent/WO2010122326A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/10Metal compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/30Sulfur-, selenium- or tellurium-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/08Polyethers derived from hydroxy compounds or from their metallic derivatives
    • C08L71/10Polyethers derived from hydroxy compounds or from their metallic derivatives from phenols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/08Polyethers derived from hydroxy compounds or from their metallic derivatives
    • C08L71/10Polyethers derived from hydroxy compounds or from their metallic derivatives from phenols
    • C08L71/12Polyphenylene oxides

Definitions

  • This invention relates to polymeric materials and particularly, although not exclusively, relates to polymeric materials with improved Notched Izod Impact Strength.
  • Notched Izod Impact Strength may be assessed in accordance with ISO180 wherein a specimen 2 as shown in figure 1 is held as a vertical cantilevered beam and is broken by a pendulum. Impact occurs on the notched side of the specimen.
  • the NIIS test may be of use in assessing the strength of parts made from polymeric materials which have a notch (or a shape similar to a notch) as part of the design or may be of use in assessing the impact on the strength of a part by damage which may produce a notch (or a shape similar to a notch) in the part.
  • the notch sensitivity is, in some cases, a potential cause of failure of an implant.
  • dynamic stabilization rods may be pre-notched during manufacture or may be notched during the surgical procedure. The notched areas have been identified as possible failure points.
  • notch sensitivity may be important in sports medicine applications (e.g. for suture anchors and screws), in trauma (e.g. for plates, nails and screws) and in orthopaedics (e.g. for acetabular cups, femoral heads and humeral heads).
  • NIIS is important, particularly if there is a risk that a part may become damaged so that a notch is defined.
  • m,r,s,t,v,w and z independently represent zero or a positive integer
  • E and E' independently represent an oxygen or a sulphur atom or a direct link
  • G represents an oxygen or sulphur atom, a direct link or a -O-Ph-0- moiety
  • Ph represents a phenyl group and Ar is selected from one of the following moieties (i)**, (i) to (iv) which is bonded via one or more of its phenyl moieties to adjacent moieties
  • a phenyl moiety has 1 ,4-, linkages to moieties to which it is bonded.
  • the middle phenyl may be 1 ,4- or 1 ,3-substituted. It is preferably 1 ,4-substituted.
  • Said polymeric material may include more than one different type of repeat unit of formula I; and more than one different type of repeat unit of formula II; and more than one different type of repeat unit of formula III. Preferably, however, only one type of repeat unit of formula I, Il and/or III is provided.
  • Said moieties I, Il and III are suitably repeat units.
  • units I, Il and/or III are suitably bonded to one another - that is, with no other atoms or groups being bonded between units I, Il and III.
  • Phenyl moieties in units I, Il and III are preferably not substituted. Said phenyl moieties are preferably not cross-linked.
  • the respective phenylene moieties may independently have 1 ,4- or 1 ,3-linkages to the other moieties in the repeat units of formulae Il and/or III.
  • said phenylene moieties have 1 ,4- linkages.
  • the polymeric chain of the polymeric material does not include a -S- moiety.
  • G represents a direct link.
  • "a” represents the mole % of units of formula I in said polymeric material, suitably wherein each unit I is the same;
  • "b” represents the mole % of units of formula Il in said polymeric material, suitably wherein each unit Il is the same;
  • "c” represents the mole % of units of formula III in said polymeric material, suitably wherein each unit III is the same.
  • a is in the range 45-100, more preferably in the range 45-55, especially in the range 48-52.
  • the sum of b and c is in the range 0-55, more preferably in the range 45-55, especially in the range 48-52.
  • the ratio of a to the sum of b and c is in the range 0.9 to 1.1 and, more preferably, is about 1.
  • the sum of a, b and c is at least 90, preferably at least 95, more preferably at least 99, especially about 100.
  • said polymeric material consists essentially of moieties I, Il and/or III.
  • Said polymeric material may be a homopolymer having a repeat unit of general formula
  • A, B, C and D independently represent 0 or 1 and E,E',G,Ar,m,r,s,t,v,w and z are as described in any statement herein.
  • m is in the range 0-3, more preferably 0-2, especially 0-1.
  • r is in the range 0-3, more preferably 0-2, especially 0-1.
  • t is in the range 0-3, more preferably 0-2, especially 0-1.
  • s is 0 or 1.
  • v is 0 or 1.
  • w is 0 or 1.
  • z is 0 or 1.
  • said polymeric material is a homopolymer having a repeat unit of general formula IV.
  • Ar is selected from the following moieties (xi)** and (vii) to (x)
  • the middle phenyl may be 1 ,4- or 1 ,3-substituted. It is preferably 1 ,4-substituted.
  • Suitable moieties Ar are moieties (i), (ii), (iii) and (iv) and, of these, moieties (i), (ii) and (iv) are preferred.
  • Other preferred moieties Ar are moieties (vii), (viii), (ix) and (x) and, of these, moieties (vii), (viii) and (x) are especially preferred.
  • polymeric materials are polymers (or copolymers) which consist essentially of phenyl moieties in conjunction with ketone and/or ether moieties. That is, in the preferred class, said polymeric material does not include repeat units which include -S-, -SO 2 - or aromatic groups other than phenyl.
  • Preferred polymeric materials of the type described include:
  • Said polymeric material may be amorphous or semi-crystalline. Said polymeric material is preferably semi-crystalline.
  • the level and extent of crystallinity in a polymer is preferably measured by wide angle X-ray diffraction (also referred to as Wide Angle X-ray Scattering or WAXS), for example as described by Blundell and Osborn (Polymer 24, 953, 1983). Alternatively, crystallinity may be assessed by Differential Scanning Calerimetry (DSC).
  • DSC Differential Scanning Calerimetry
  • the level of crystallinity in said polymeric material may be at least 1 %, suitably at least 3%, preferably at least 5% and more preferably at least 10%. In especially preferred embodiments, the crystallinity may be greater than 30%, more preferably greater than 40%, especially greater than 45%.
  • the main peak of the melting endotherm (Tm) for said polymeric material (if crystalline) may be at least 300 0 C.
  • Said polymeric material may consist essentially of one of units (a) to (f) defined above.
  • Said polymeric material preferably comprises, more preferably consists essentially of, a repeat unit of formula (XX)
  • t1 , and w1 independently represent 0 or 1 and v1 represents 0, 1 or 2.
  • said polymeric material is selected from polyetheretherketone, polyetherketone, polyetherketoneetherketoneketone and polyetherketoneketone. In a more preferred embodiment, said polymeric material is selected from polyetherketone and polyetheretherketone. In an especially preferred embodiment, said polymeric material is polyetheretherketone.
  • Said polymeric material may have a Notched Izod Impact Strength (specimen 80mm x 10mm x 4mm with a cut 0.25mm notch (Type A), tested at 23 0 C, in accordance with ISO180) (hereinafter referred to as NIIS) of at least 4KJm “2 , preferably at least 5KJm "2 , more preferably at least 6KJm "2 .
  • Said Notched Izod Impact Strength measured as aforesaid, may be less than 10KJm "2 , suitably less than 8KJm "2 .
  • NIIS hereinafter referred to is measured as aforesaid, unless otherwise stated.
  • Said polymeric material suitably has a melt viscosity (MV) of at least 0.06 kNsm " , preferably has a MV of at least 0.085 kNsm “2 , more preferably at least 0.12 kNsm “2 , especially at least 0.14 kNsm “2 .
  • MV melt viscosity
  • MV is suitably measured using capillary rheometry operating at 400 0 C at a shear rate of 1000s "1 using a tungsten carbide die, 0.5x3.175mm.
  • Said polymeric material may have a MV of less than 1.00 kNsm "2 , preferably less than 0.5 kNsm "2 .
  • Said polymeric material may have a MV in the range 0.09 to 0.5 kNsm " , preferably in the range 0.14 to 0.5 kNsm -2
  • Said polymeric material may have a tensile strength, measured in accordance with ISO527 (specimen type 1 b) tested at 23 0 C at a rate of 50mm/minute of at least 20 MPa, preferably at least 60 MPa, more preferably at least 80 MPa.
  • the tensile strength is preferably in the range 80-110 MPa, more preferably in the range 80-100 MPa.
  • Said polymeric material may have a flexural strength, measured in accordance with ISO178 (80mm x 10mm x 4mm specimen, tested in three-point-bend at 23 0 C at a rate of 2mm/minute) of at least 50 MPa, preferably at least 100 MPa, more preferably at least 145 MPa.
  • the flexural strength is preferably in the range 145-180MPa, more preferably in the range 145-164 MPa.
  • Said polymeric material may have a flexural modulus, measured in accordance with ISO178 (80mm x 10mm x 4mm specimen, tested in three-point-bend at 23 0 C at a rate of 2mm/minute) of at least 1 GPa, suitably at least 2 GPa, preferably at least 3 GPa, more preferably at least 3.5 GPa.
  • the flexural modulus is preferably in the range 3.5-4.5 GPa, more preferably in the range 3.5-4.1 GPa.
  • the aforesaid characteristics of said polymeric material refer to polymeric material per se (ie unfilled).
  • Said polymeric material may be amorphous or semi-crystalline. It is preferably semi-crystalline.
  • the level and extent of crystallinity in a polymer is preferably measured by wide angle X-ray diffraction (also referred to as Wide Angle X-ray Scattering or WAXS), for example as described by Blundell and Osborn (Polymer 24, 953, 1983).
  • WAXS Wide Angle X-ray Scattering
  • crystallinity may be assessed by Differential Scanning Calerimetry (DSC).
  • the level of crystallinity of said polymeric material may be at least 1 %, suitably at least 3%, preferably at least 5% and more preferably at least 10%. In especially preferred embodiments, the crystallinity may be greater than 25%.
  • the main peak of the melting endotherm (Tm) of said polymeric material (if crystalline) may be at least 300°C.
  • Said barium sulphate may have a D 10 particle size in the range 0.1 to 1.O ⁇ m; a D 50 particle size suitably in the range 0.5 ⁇ m to 2 ⁇ m and a D 90 particle size suitably in the range 1.0 ⁇ m to 5 ⁇ m.
  • the D 10 may be in the range 0.1 to 0.6 ⁇ m, preferably 0.2 to 0.5 ⁇ m.
  • the D 50 may be in the range 0.7 ⁇ m to 1.5 ⁇ m, preferably 0.8 to 1.3 ⁇ m.
  • the D 90 may be in the range 1.5 to 3 ⁇ m, preferably in the range 2.0 to 2.5 ⁇ m.
  • the ratio of the wt% of barium sulphate to the wt% of said polymeric material may be greater than 0.04, is suitably greater than 0.07, is preferably greater than 0.10, is more preferably greater than 0.13, and is especially greater than 0.16. In some cases, said ratio may be greater than 0.20 or 0.22. The ratio may be less than 0.4, or less than 0.3.
  • Said barium sulphate is preferably intimately mixed with the polymeric material, suitably so the barium sulphate and polymeric material define a substantially homogenous mixture.
  • the wt% of barium sulphate in a composition which includes barium sulphate and said polymeric material may be at least 5wt%, suitably at least 8wt%, preferably at least 10wt%, more preferably at least 13wt%, especially at least 16wt%. Said wt% of barium sulphate may be less than 30wt% or less than 25wt%.
  • the wt% of said polymeric material in a composition which includes barium sulphate (and, optionally water as hereinafter described) may be at least 40wt%, preferably at least 45wt%, more preferably at least 50wt%.
  • compositions may consist essentially of barium sulphate and said polymeric material.
  • said composition may include one or more other fillers, for example carbon fibre.
  • a composition may include up to 35wt% or up to 30wt% carbon fibre. When carbon fibre is included the composition suitably includes 25-35wt% carbon fibre.
  • Said barium sulphate may be used to increase the NIIS of said polymeric material by at least 10 KJm “2 , suitably by at least 20KJm “2 , preferably by at least 30 KJm “2 , more preferably by at least 40 KJm “2 , measured in accordance with ISO180. Said NIIS may be increased by less than 60KJm "2 .
  • the ratio of the NIIS of a composition which includes barium sulphate as described to the NIIS of an otherwise identical composition which does not include barium sulphate as described may be at least 2, suitably at least 4, preferably at least 6, more preferably at least 8. The ratio may be less than 15 or less than 11.
  • the NIIS of a composition comprising said polymeric material and barium sulphate is increased when the composition includes water. Accordingly, the invention extends to the use of barium sulphate and water for increasing the impact strength of a polymeric material as described according to the first aspect.
  • the ratio of the wt% of water to barium sulphate may be in the range 0.01 to 0.2, preferably in the range 0.02 to 0.15. The ratio is suitably less than 0.10, preferably less than 0.05, more preferably less than 0.04.
  • the wt% of water in a composition which also includes barium sulphate and said polymeric material may be at least 0.10wt%, preferably at least 0.2wt%, more preferably at least 0.30wt%, especially at least 0.40wt%.
  • the wt% of water may be less than 1wt%, less than 0.8wt%, less than 0.6wt%.
  • the wt% of water may be in the range 0.3 to 0.7wt%, suitably 0.4 to 0.6wt%.
  • composition comprising polymeric material and barium sulphate may be provided in any desired form, for example as a stock shape, film or fibre.
  • the NIIS of said composition comprising polymeric material and barium sulphate has been found to be reversible in dependence upon whether water is present or not.
  • a part made from a composition comprising barium sulphate and said polymeric material to be used in a moist and/or wet environment.
  • the invention extends to the use of barium sulphate for increasing the impact strength of a polymeric material according to the first aspect used in making a part for use in a moist and/or wet environment.
  • Said environment may include water in a liquid state. Water in a liquid state may contact the part in use.
  • Said environment may be substantially enclosed and suitably includes a source of water and/or water vapour.
  • Said environment may comprise a human or animal body (especially the former) and preferably comprises an internal region of a human body.
  • Said part may be an implant.
  • a method of increasing the impact strength of a polymeric material as described according to the first aspect comprising forming a composition comprising said polymeric material and barium sulphate.
  • composition, polymeric material, barium sulphate, impact strength and any other features of the invention of the first aspect may be applied to the invention of the second aspect mutatis mutandis.
  • the method may comprise selecting a said polymeric material and melt compounding it with barium sulphate.
  • the method may comprise treating the composition to increase the level of water contained therewithin.
  • a method of increasing the impact strength of a part which comprises a polymeric material as described according to the first aspect and barium sulphate, the method comprising treating the part to increase the level of water contained therewithin.
  • the part may have any feature of the composition described according to the first and second aspects after said treatment.
  • the wt% of water in said part which also includes barium sulphate and said polymeric material may be at least 0.10wt%, preferably at least 0.20wt%, more preferably at least 0.30wt%, especially at least 0.40wt%.
  • the wt% of water may be less than 1wt%, less than 0.8wt%, less than 0.6wt%.
  • the wt% of water may be in the range 0.3 to 0.7wt%, suitably 0.4 to 0.6wt%.
  • the wt% of barium sulphate in said part may be at least 5wt%, suitably at least 8wt%, preferably at least 10wt%, more preferably at least 13wt%, especially at least 16wt%. Said wt% of barium sulphate may be less than 30wt% or less than 25wt%.
  • the wt% of said polymeric material in said part may be at least 40wt%. In some cases, greater than 99wt% of said part may consist essentially of barium sulphate and said polymeric material. In other cases, said part may include one or more other fillers, for example carbon fibre.
  • a part may include up to 35wt% or up to 30wt% carbon fibre. When carbon fibre is included the part suitably includes 25-35wt% carbon fibre.
  • Treatment of said part preferably involves an active treatment. It preferably comprises a treatment at a temperature of greater than 4O 0 C, suitably at greater than 6O 0 C, preferably at greater than 8O 0 C.
  • the part may be treated with steam.
  • the part may be treated under a pressure of greater than ambient pressure, for example greater than 2 bar or 4 bar. Treatment may involve an autoclave and/or may involve steam sterilisation.
  • the invention extends to a part made in a method of the third aspect.
  • a part which is made from a composition comprising a polymeric material as described according to the first aspect and barium sulphate.
  • said part has been treated to increase its NIIS.
  • the part may have been treated in a method of the second or third aspects
  • the part is preferably spaced from and/or separated from its position of intended use.
  • the part is preferably outside an environment in which it is intended to be used.
  • the part may be outside the body but suitably has increased impact strength by virtue of the treatment to which it has been subjected and/or other features of the part described herein.
  • Said part is preferably an implantable part, for example an implantable prosthesis, such as an orthopaedic implant, for implantation in a human body. It may be a dynamic stabilisation rod or for use in a prosthetic hip joint.
  • Said part may comprise greater than 50wt% of said polymeric material (preferably polyetheretherketone), at least 8wt% (preferably at least 10wt% or at least 13wt%) barium sulphate and at least 0.3wt% (preferably at least 0.45wt%) of water.
  • said part includes at least 55wt% polyetheretherketone, at least 10wt% barium sulphate and at least 0.4wt% of water.
  • the part may include 0 to 34.6wt% of other fillers, for example carbon fibre.
  • a package which is suitably sterile, comprising a part according to the fourth aspect or a part, the impact strength of which has been increased, in accordance with the third aspect.
  • Said part may be arranged in a package from which air has been removed.
  • it may be vacuum packed for example in a metal (e.g. aluminium) lined receptacle.
  • composition comprising a polymeric material according to the first aspect and barium sulphate in the manufacture of an implantable prosthesis for example an orthopaedic implant.
  • an implantable prosthesis for example an orthopaedic implant, the method comprising:
  • composition comprising a said polymeric material according to the first aspect and barium sulphate;
  • melt processing for example extruding or injection moulding, said composition to define the part or a precursor of said part.
  • the impact strength of the part may be increased as described according to the second or third aspects.
  • PEEK-OPTIMA LT1 (Trade Mark) - an implantable grade of polyetheretherketone having an MV of 0.46 KNsnrf 2 obtained from Invibio Limited, Thornton, Cleveleys, UK.
  • Barium sulphate was added to PEEK-OPTIMA via an extrusion compounding process.
  • the barium sulphate can be gravimetrically metered and fed through a side feeder into a twin screw extruder, where it is combined with plasticized polymer melt and intimately mixed to provide a uniform dispersion of the filler within the polymer.
  • the filler may be added up to 60% by weight of the polymer, depending upon the desired mechanical properties of the compound. Extrusion of this mixture through a die generates strands or laces that cool and solidify before being chopped into small granules in preparation for subsequent processing.
  • Example 1 The compound prepared in Example 1 was injection moulded to manufacture test pieces, in accordance with the requirements of ISO 527-2 (sample geometry 1 B), ISO 178, and ISO 180 for tensile strength, flexural strength and notched Izod impact testing respectively.
  • Test pieces were prepared as described in Examples 1 and 2 containing PEEK-OPTIMA LT1 and either 4wt% or 20wt% of barium sulphate and subjected to a range of different treatments as described in Table 1.
  • Test pieces were prepared as described in Example 2 with different filler loadings, varying between 4 to 20wt% and the Notched Izod Impact Strength assessed in accordance with ISO180 under two different sets of conditions - firstly, after drying in an oven at 12O 0 C for 72 hours; and, secondly, after sterilisation in steam for 20 minutes at 134 0 C, soaking in water for 15 hours followed by further sterilisation in steam for 20 minutes at 134 0 C. Results are provided in Table 3. Table 3
  • Respective test pieces comprising 4wt% and 20wt% barium sulphate were prepared and tested in cyclical testing.
  • the effect on impact strength of the incorporation of barium sulphate and water into polyaryletherketone may have many industrial applications. It may be of particular utility for making parts which are used in a moist environment so that the optimum amount of water (believed to be about 0.15wt%) may be maintained within a composition which comprises the polyaryletherketone and barium sulphate.
  • a suitably moist environment is found in the human body and, consequently, parts made from polyaryletherketone and barium sulphate and, optionally, other fillers, may be pre-conditioned so they contain water, for example 0.15wt%, and then implanted. When implanted, the water level is maintained and so, therefore, is the surprising improvement in impact strength. It is also found that other properties, for example other mechanical properties of the polyaryletherketone are not significantly detrimentally affected by incorporation of barium sulphate and/or water. Furthermore the polyaryletherketone is chemically unchanged.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Prostheses (AREA)
PCT/GB2010/050631 2009-04-21 2010-04-16 Polymeric materials comprising barium sulphate Ceased WO2010122326A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP10716014.5A EP2421914B1 (en) 2009-04-21 2010-04-16 Polymeric materials comprising barium sulphate
BRPI1014972A BRPI1014972A2 (pt) 2009-04-21 2010-04-16 materiais poliméricos contendo sulfato de bário.
JP2012506573A JP5732044B2 (ja) 2009-04-21 2010-04-16 硫酸バリウムを含むポリマー材料
US13/265,601 US20120101185A1 (en) 2009-04-21 2010-04-16 Polymeric materials comprising barium sulphate
AU2010240703A AU2010240703A1 (en) 2009-04-21 2010-04-16 Polymeric materials comprising barium sulphate
CN201080017478.5A CN102405254B (zh) 2009-04-21 2010-04-16 包含硫酸钡的聚合物材料
CA2758605A CA2758605A1 (en) 2009-04-21 2010-04-16 Polymeric materials comprising barium sulphate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0906823.0A GB2469991B (en) 2009-04-21 2009-04-21 Polymeric materials
GB0906823.0 2009-04-21

Publications (1)

Publication Number Publication Date
WO2010122326A1 true WO2010122326A1 (en) 2010-10-28

Family

ID=40774715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2010/050631 Ceased WO2010122326A1 (en) 2009-04-21 2010-04-16 Polymeric materials comprising barium sulphate

Country Status (11)

Country Link
US (1) US20120101185A1 (enExample)
EP (1) EP2421914B1 (enExample)
JP (1) JP5732044B2 (enExample)
KR (1) KR20110139308A (enExample)
CN (1) CN102405254B (enExample)
AU (1) AU2010240703A1 (enExample)
BR (1) BRPI1014972A2 (enExample)
CA (1) CA2758605A1 (enExample)
GB (1) GB2469991B (enExample)
TW (1) TW201041973A (enExample)
WO (1) WO2010122326A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017017419A1 (en) * 2015-07-24 2017-02-02 Victrex Manufacturing Limited Polymeric materials

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008106625A2 (en) 2007-02-28 2008-09-04 University Of Notre Dame Du Lac Porous composite biomaterials and related methods
US11179243B2 (en) 2007-02-28 2021-11-23 Happe Spine Llc Implantable devices
GB2488111A (en) * 2011-02-14 2012-08-22 Invibio Ltd Components incorporating bioactive material
GB201219686D0 (en) * 2012-11-01 2012-12-12 Invibio Ltd Orthopaedic polymer-on-polymer bearings
WO2015170649A1 (ja) * 2014-05-07 2015-11-12 株式会社トクヤマデンタル 樹脂複合材料および樹脂複合材料の製造方法
CN105647109A (zh) * 2014-12-05 2016-06-08 黑龙江鑫达企业集团有限公司 一种聚醚醚酮/硫酸钡复合材料及其制备方法
US11352480B2 (en) 2016-03-18 2022-06-07 Ticona Llc Polyaryletherketone composition
EP3594309A4 (en) * 2017-03-08 2020-12-16 Otsuka Chemical Co., Ltd. FRICTION MATERIAL COMPOSITION, FRICTION MATERIAL AND FRICTION ELEMENT
US11118053B2 (en) 2018-03-09 2021-09-14 Ticona Llc Polyaryletherketone/polyarylene sulfide composition
EP4520517A3 (en) 2019-03-12 2025-05-07 Happe Spine LLC Implantable medical device with thermoplastic composite body and method for forming thermoplastic composite body
GB2597063A (en) * 2020-07-09 2022-01-19 Invibio Device Component Mfg Limited Composite materials

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423510A1 (en) * 1989-10-20 1991-04-24 General Electric Company Highly dense thermoplastic molding compositions
EP0451458A1 (en) * 1990-04-10 1991-10-16 General Electric Company Polymer mixture which comprises polyphenylene ether, polyoctenylene and TiO2 or BaSO4
JP2005171242A (ja) * 2003-11-21 2005-06-30 Toray Ind Inc ポリフェニレンスルフィド樹脂組成物
GB2435648A (en) * 2006-03-01 2007-09-05 Invibio Ltd A polymeric material assembly
US20080234532A1 (en) * 2005-10-22 2008-09-25 Invibio Limited Fiducial marker

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663213B1 (de) * 1994-01-18 2001-03-21 Sci-Can, A Division Of Lux And Zwingenberger Ltd. Sterilisationskammer zur Dampfsterilisation von ärztlichen Instrumenten, Implantaten und ähnlichem
US6692499B2 (en) * 1997-07-02 2004-02-17 Linvatec Biomaterials Oy Surgical fastener for tissue treatment
US7238203B2 (en) * 2001-12-12 2007-07-03 Vita Special Purpose Corporation Bioactive spinal implants and method of manufacture thereof
DE10226266B4 (de) * 2002-06-07 2005-09-15 Ks Gleitlager Gmbh Gleitlagerverbundwerkstoff
DE10228420A1 (de) * 2002-06-25 2004-02-05 Heraeus Kulzer Gmbh & Co. Kg Verfahren zur Keimreduktion und/oder Sterilisation von Abformmaterialien
WO2005000364A2 (en) * 2003-06-23 2005-01-06 Novasterilis Inc. Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
US7638091B2 (en) * 2004-07-02 2009-12-29 Sabic Innovative Plastics Ip B. V. Methods of sterilizing polycarbonate articles and methods of manufacture
US20060255510A1 (en) * 2005-05-13 2006-11-16 Spx Corporation X-ray detection of polymer components in material processing
WO2007016795A1 (de) * 2005-08-09 2007-02-15 Dr.H.C. Robert Mathys Stiftung Vorrichtung für den künstlichen ersatz einer gelenkartikulation in mensch und tier
HUE025071T2 (en) * 2005-08-26 2016-01-28 Becton Dickinson Co Method for sterilizing elastomeric articles
GB0521536D0 (en) * 2005-10-22 2005-11-30 Invibio Ltd Fiducial marker
CA2627895C (en) * 2005-11-04 2014-10-14 Ppd Meditech Porous material and method for fabricating same
US20070191946A1 (en) * 2006-01-31 2007-08-16 Sdgi Holdings, Inc. Intervertebral spinal implant devices and methods of use
CN101400744A (zh) * 2006-02-21 2009-04-01 萨克特本化学有限责任公司 硫酸钡
US20070270691A1 (en) * 2006-05-19 2007-11-22 Bailey Michael L Radiopaque compositions, articles and methods of making and using same
US20090318594A1 (en) * 2006-08-25 2009-12-24 Sachtleben Chemie Gmbh Barium sulfate-containing composite
EP2063817A4 (en) * 2006-09-15 2012-04-18 Pioneer Surgical Technology Inc ARTICULAR ARTHROPLASTY DEVICES HAVING JOINT ELEMENTS

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423510A1 (en) * 1989-10-20 1991-04-24 General Electric Company Highly dense thermoplastic molding compositions
EP0451458A1 (en) * 1990-04-10 1991-10-16 General Electric Company Polymer mixture which comprises polyphenylene ether, polyoctenylene and TiO2 or BaSO4
JP2005171242A (ja) * 2003-11-21 2005-06-30 Toray Ind Inc ポリフェニレンスルフィド樹脂組成物
US20080234532A1 (en) * 2005-10-22 2008-09-25 Invibio Limited Fiducial marker
GB2435648A (en) * 2006-03-01 2007-09-05 Invibio Ltd A polymeric material assembly

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BLUNDELL; OSBORN, POLYMER, vol. 24, 1983, pages 953
DATABASE WPI Week 200550, Derwent World Patents Index; AN 2005-490962, XP002589548 *
INVIBIO© BIOMATERIAL SOLUTIONS: "PEEK-OPTIMA POLYMER Performance Purity Flexibility Endurance", 2004, XP002588809, Retrieved from the Internet <URL:http://www.ppchase.com/cayenne/download/cay14.pdf> [retrieved on 20100624] *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017017419A1 (en) * 2015-07-24 2017-02-02 Victrex Manufacturing Limited Polymeric materials

Also Published As

Publication number Publication date
EP2421914A1 (en) 2012-02-29
TW201041973A (en) 2010-12-01
JP5732044B2 (ja) 2015-06-10
KR20110139308A (ko) 2011-12-28
CA2758605A1 (en) 2010-10-28
GB2469991B (en) 2013-08-07
CN102405254B (zh) 2015-02-25
JP2012524826A (ja) 2012-10-18
GB0906823D0 (en) 2009-06-03
GB2469991A (en) 2010-11-10
CN102405254A (zh) 2012-04-04
AU2010240703A1 (en) 2011-11-10
US20120101185A1 (en) 2012-04-26
EP2421914B1 (en) 2016-03-30
BRPI1014972A2 (pt) 2016-04-26

Similar Documents

Publication Publication Date Title
WO2010122326A1 (en) Polymeric materials comprising barium sulphate
EP2300516B1 (en) Polymeric materials
Hasırcı et al. Versatility of biodegradable biopolymers: degradability and an in vivo application
US9650476B2 (en) Sequentially cross-linked polyethylene
US20210129396A1 (en) Components incorporating bioactive material
US8729150B2 (en) Polymeric materials
EP1801135A1 (en) Perfluorocyclobutane crosslinked hydrogels
Targonska et al. New way to obtain the poly (L-lactide-co-D, L-lactide) blend filled with nanohydroxyapatite as biomaterial for 3D-printed bone-reconstruction implants
EP1905463A1 (en) Implantable composite for orthopedic devices made of polymer and ceramic particles
US20210008252A1 (en) Thermoplastic materials incorporating bioactive inorganic additives
Sim et al. Bioabsorbable PLA/PHA composite pins for orthopedic applications: In vitro and in vivo study
Yerli et al. Characterisation of 3D printed hydroxyapitate powder (HAp) filled polylactic acid (PLA) composites
CN111001043A (zh) 可吸收自锁定颈椎融合器及其制备方法
Rich et al. Lactic acid based PEU/HA and PEU/BCP composites: dynamic mechanical characterization of hydrolysis
EP2139420A2 (en) Fiducial marker
Ward Mechanical and structural performance of melt-processable bioresorbable engineering nanocomposites
Targońska et al. Effect of Carbon Fibers Coated With Nanosized Hydroxyapatite on the Strength and Biocompatibility of Polymer Composites
EP4568715A1 (en) 3d printed bioactive scaffolds
Amestoy Muñoz Materiales compuestos multifuncionales para aplicaciones médicas: uso de sulfato de bario y nanotubos de carbono con poliésteres bioabsorbibles
WO2025196823A1 (en) Ultra high molecular weight polyethylene polymer blends for manufacturing of injection moldable orthopedic implant

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080017478.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10716014

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 7730/DELNP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2758605

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012506573

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2010716014

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20117026438

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2010240703

Country of ref document: AU

Date of ref document: 20100416

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13265601

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI1014972

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI1014972

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20111017